This inventor holds 4 USPTO granted patents. Top assignee: The Green Cross Corporation. Active years: 1994-1999.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Hirakata, JP (1994)
- Osaka, JP (1995 - 1999)
Company Filing History:
Years Active: 1994-1999
Title: Kazuya Takeshima: Innovator in Recombinant Human Serum Albumin
Introduction
Kazuya Takeshima is a prominent inventor based in Osaka, Japan. He has made significant contributions to the field of biotechnology, particularly in the purification of recombinant human serum albumin. With a total of 4 patents to his name, his work has implications for pharmaceutical preparations and medical applications.
Latest Patents
Takeshima's latest patents focus on the process for producing recombinant human serum albumin. This innovative process involves a series of purification steps, including ultrafiltration, heat treatment, acid treatment, and additional ultrafiltration. The method also utilizes cation exchangers, hydrophobic chromatography carriers, and anion exchangers, along with salting-out techniques. The result is a pure form of human serum albumin that is free from proteinous and polysaccharide contaminants, making it suitable for pharmaceutical use. Furthermore, the process allows for further purification by treating the recombinant human serum albumin with specific conditions, ensuring that the final product is devoid of producer host-related substances and other contaminants.
Career Highlights
Kazuya Takeshima has established himself as a key figure in his field through his innovative research and development efforts. His work at The Green Cross Corporation has positioned him at the forefront of advancements in biotechnology. His patents reflect a commitment to improving the quality and efficacy of pharmaceutical products.
Collaborations
Takeshima has collaborated with notable colleagues, including Takao Ohmura and Akinori Sumi. These partnerships have contributed to the success of his research and the development of his patented processes.
Conclusion
Kazuya Takeshima's contributions to the field of biotechnology, particularly in the purification of recombinant human serum albumin, highlight his innovative spirit and dedication to advancing medical science. His work continues to impact the pharmaceutical industry positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile